
A systematic review finds limited evidence of benefit.

Your AI-Trained Oncology Knowledge Connection!


A systematic review finds limited evidence of benefit.

Goal is to identify tests and treatments of little to no benefit.

Recommendations issued by the NCI and ASCO.

It's been well established now that cancer survivorship begins on the day of diagnosis. Despite the positive spin that this presents for patients, families, friends, and coworkers, most people still associate cancer survivorship with completing treatment and getting on with life.

IBM's computer will be used to identify effective cancer care.

Occupational exposure to hazardous drugs is a known risk of working in settings in which these drugs are administered.

Underlying mechanism for increased risk now defined.

Two question survey works as well as longer surveys.

Researchers find that patients are not referred for supportive care services.

The IOM makes 10 recommendations for improving care.

Found to be helpful for patients with head and neck cancer.

A hot topic of discussion at the American Society of Clinical Oncology (ASCO) meeting in June was the Patient Protection and Affordable Care Act (often referred to as the ACA) and what it means for the future of oncology care in the United States.

Healthcare providers have until September 23, 2013 to comply.

PACES trial will evaluate 2 drugs to prevent colon adenomas.

Employers bear a large number of costs.

The aim of these courses is to improve the care of patients aged 15-39.

More is now known about the types of HPV that increase risk.

Yes, it's been found there and on other surprising surfaces.

Standards established by an interprofessional workgroup.

It is no surprise that increasing rates of obesity are linked to increasing cancer incidence, but what is interesting is just how bad things are now, and how bad they are predicted to become in the years ahead.

Especially helpful for newly diagnosed patients.

Although the number of survivors is impressive, survivorship also brings challenges, as many cancer survivors experience long-term physical and psychosocial effects of the disease and its treatment.

New system hopes to improve toxicity grading accuracy.

Another year, another survivors' day.

New resource provides mechanism for viewing a hospital's billing track record.

Goal of proposed law is to improve patient care and reduce the nursing shortage.

The majority of the new oncology drugs approved in 2012 are oral agents, and by reviewing the indications for these agents, it's easy to see how genetics impacts the agent's efficacy.

A problem for many people undergoing cancer treatment.

Few baby boomers are facing the facts about aging.

USPSTF is inviting comments on screening by primary care professionals.

Published: April 19th 2012 | Updated:

Published: April 23rd 2012 | Updated:

Published: May 1st 2012 | Updated:

Published: May 9th 2012 | Updated:

Published: May 21st 2012 | Updated:

Published: May 31st 2012 | Updated: